s6y

VivoSim Labs, INC.

Ticker
VIVS
CIK
1497253
Industry
Biological Products, (No Diagnostic Substances)
Formerly
ORGANOVO HOLDINGS, INC., REAL ESTATE RESTORATION & RENTAL, INC.

Financials 72

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-K Annual Report for period ending Mar 31, 2026
  4. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Mar 31, 2026
  5. 10-Q Quarterly Report for period ending Dec 31, 2025
  6. 10-Q Quarterly Report for period ending Sep 30, 2025
  7. 10-Q Quarterly Report for period ending Jun 30, 2025
  8. 10-K/A Annual Report for period ending Mar 31, 2025
  9. 10-K Annual Report for period ending Mar 31, 2025
  10. 10-Q Quarterly Report for period ending Dec 31, 2024

All 72 financials filings

News 193

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 193 news filings

Ownership 337

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 3 Initial statement of beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 3 Initial statement of beneficial ownership of securities

All 337 ownership filings

Prospectus 86

  1. S-1 General form of registration statement for all companies including face-amount certificate companies
  2. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  3. S-1/A General form of registration statement for all companies including face-amount certificate companies
  4. S-1 General form of registration statement for all companies including face-amount certificate companies
  5. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  6. RW Registration Withdrawal Request
  7. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  8. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  9. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  10. S-1 General form of registration statement for all companies including face-amount certificate companies

All 86 prospectus filings

Proxies 43

  1. DEF 14A Definitive proxy statements
  2. PRER14A Preliminary revised proxy soliciting materials
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEF 14A Definitive proxy statements
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEF 14A Definitive proxy statements
  10. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

All 43 proxies filings

Other 89

  1. ARS Annual report to security holders
  2. SCHEDULE 13G/A
  3. EFFECT Notice of Effectiveness
  4. SCHEDULE 13G
  5. EFFECT Notice of Effectiveness
  6. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  7. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 89 other filings